NASDAQ:YJYunji Stock Price, Forecast & News

Yunji's stock was trading at $3.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, YJ shares have decreased by 26.8% and is now trading at $2.82. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Yunji in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Yunji.

Yunji is scheduled to release its next quarterly earnings announcement on Thursday, August 27th 2020. View our earnings forecast for Yunji.

Yunji Inc (NASDAQ:YJ) issued its earnings results on Wednesday, June, 3rd. The company reported $0.12 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.05 by $0.07. The business earned $232.91 million during the quarter. Yunji had a negative net margin of 1.55% and a negative return on equity of 7.60%. View Yunji's earnings history.

Media coverage about YJ stock has been trending negative on Friday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Yunji earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Yunji.

Some companies that are related to Yunji include Sally Beauty (SBH), 1-800-Flowers.Com (FLWS), Star Group (SGU), Titan Machinery (TITN), Secoo (SECO), Kirkland's (KIRK) and SpendSmart Networks (SSPC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Yunji investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Wells Fargo & Co (WFC), CBTX (CBTX), Energy Transfer LP Unit (ET), Gilead Sciences (GILD), General Motors (GM), GlaxoSmithKline (GSK), IBM (IBM) and Kohl's (KSS).

(YJ) raised $155 million in an initial public offering (IPO) on Friday, May 3rd 2019. The company issued 13,500,000 shares at a price of $11.00-$12.00 per share. Morgan Stanley, Credit Suisse, J.P. Morgan and CICC served as the underwriters for the IPO.

Yunji trades on the NASDAQ under the ticker symbol "YJ."

Shares of YJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of YJ stock can currently be purchased for approximately $2.82.

Yunji has a market capitalization of $608.17 million and generates $1.68 billion in revenue each year. The company earns $-18,070,000.00 in net income (profit) each year or ($1.31) on an earnings per share basis. Yunji employs 1,334 workers across the globe.

The official website for Yunji is www.yunjiglobal.com.

Yunji's mailing address is 15/F SOUTH BUILDING HIPARK PHASE 2 XIAOSHAN DISTRICT, HANGZHOU F4, 310000. The company can be reached via phone at 86-571-8168-8920 or via email at [email protected]